BIOCRYST PHARMACEUTICALS, INC. Peo Actually Paid Comp Amt
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Peo Actually Paid Comp Amt of $1.16 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-23.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:PeoActuallyPaidCompAmt · last filed 2026-04-23
| Period end | Peo Actually Paid Comp Amt 12 month |
|---|---|
| 2025-12-31 | $1.16M DEF 14A · filed 2026-04-23 |
| 2024-12-31 | $10.98M DEF 14A · filed 2026-04-23 |
| 2023-12-31 | -$3.69M DEF 14A · filed 2026-04-23 |
| 2022-12-31 | $4.01M DEF 14A · filed 2026-04-23 |
| 2021-12-31 | $17.05M DEF 14A · filed 2026-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |